Sc Us (Ttgp), Ltd. Bridge Bio Pharma, Inc. Transaction History
Sc Us (Ttgp), Ltd.
- $11.4 Billion
- Q2 2025
A detailed history of Sc Us (Ttgp), Ltd. transactions in Bridge Bio Pharma, Inc. stock. As of the latest transaction made, Sc Us (Ttgp), Ltd. holds 1,860,364 shares of BBIO stock, worth $105 Million. This represents 0.71% of its overall portfolio holdings.
Number of Shares
1,860,364
Previous 1,860,364
-0.0%
Holding current value
$105 Million
Previous $64.3 Million
24.91%
% of portfolio
0.71%
Previous 0.68%
Shares
2 transactions
Others Institutions Holding BBIO
# of Institutions
413Shares Held
187MCall Options Held
11.3MPut Options Held
1.93M-
Viking Global Investors LP18.6MShares$1.04 Billion2.54% of portfolio
-
Vanguard Group Inc Valley Forge, PA16.5MShares$927 Million0.01% of portfolio
-
Kohlberg Kravis Roberts & Co. L.P. New York, NY13.3MShares$746 Million22.63% of portfolio
-
Black Rock Inc. New York, NY12.4MShares$700 Million0.01% of portfolio
-
Janus Henderson Group PLC London, X09.28MShares$522 Million0.21% of portfolio
About BridgeBio Pharma, Inc.
- Ticker BBIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 148,246,000
- Market Cap $8.34B
- Description
- BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...